Neidio i’r prif gynnwys
English Cymraeg
Ymgynghoriad

Impact Assessment for new labelling provisions to protect vulnerable consumers from risks associated with consumption of raw drinking milk and cream a

In July 2015, the Food Standard Agency’s (FSA) Board concluded in its recommendations review on raw drinking milk. One for the recommendations was that risk communication, particularly to vulnerable groups, should be improved and this should include revisions to labelling requirements in England and Northern Ireland to mirror that already used in Wales.

Diweddarwyd ddiwethaf: 10 September 2019
Diweddarwyd ddiwethaf: 10 September 2019

Crynodeb o ymatebion

England, Northern Ireland and Wales

About this consultation

Consultation target audience

Raw Drinking Milk (RDM) and Cream producers in England and Northern Ireland, RDM consumers, enforcement authorities and those with an interest in RDM.

Consultation subject

In July 2015, the Food Standard Agency’s (FSA) Board concluded in its recommendations review on raw drinking milk. One for the recommendations was that risk communication, particularly to vulnerable groups, should be improved and this should include revisions to labelling requirements in England and Northern Ireland to mirror that already used in Wales. The Food Safety and Hygiene (England) Regulations 2013 and the Food Hygiene Regulations (Northern Ireland) 2006 (as amended) would need to be amended to enable the new labelling provisions to protect vulnerable consumers against the risks associated with the consumption of RDM and extend labelling provisions to all species.

Key Proposal

Currently RDM (except buffalo) would need to be labelled with the warning; “This milk has not been heat-treated and may therefore contain organisms harmful to health.” It is proposed that in England and Northern Ireland enhanced labelling is introduced to RDM from all species: ‘the FSA strongly advises that it should not be consumed by children, pregnant women, older people and those who are unwell or have chronic illness’

Consultation purpose

To provide interested parties with the opportunity to comment and express their opinions on the proposed labelling provisions to protect vulnerable consumers and the associated Impact Assessment.

Consultation pack

England, Northern Ireland and Wales

Cyhoeddi crynodeb o’r ymatebion

O fewn tri mis ar ôl i’r ymgynghoriad ddod i ben, byddwn yn anelu at gyhoeddi crynodeb o’r ymatebion a chynnwys dolen iddo ar y dudalen hon. Gallwch ddod o hyd i wybodaeth am sut yr ydym yn trin data a ddarperir mewn ymateb i ymgynghoriadau yn ein hysbysiad preifatrwydd am ymgynghoriadau.

Mwy o wybodaeth

Mae’r ymgynghoriad hwn wedi’i baratoi yn unol ag egwyddorion ymgynghori llywodraeth y DU.. Os oes Asesiad Effaith wedi’i lunio, bydd wedi’i gynnwys yn y dogfennau ymgynghori. Os na ddarparwyd Asesiad Effaith, nodir y rheswm dros hynny y ddogfen ymgynghori.